First Rounder: Henri Termeer
First Rounders - Podcast autorstwa Nature Biotechnology
Henri Termeer discusses his path to Genzyme, the approval of Ceredase and the drawn-out negotiations with eventual acquirer Sanofi. Hosted on Acast. See acast.com/privacy for more information.
